Minimal residual disease following autologous stem cell transplant in myeloma: impact on outcome is independent of induction regimen

被引：38

作者：

de Tute, Ruth M. ^{[1
]}

Rawstron, Andy C. ^{[1
]}

Gregory, Walter M. ^{[2
]}

Child, J. Anthony ^{[2
]}

Davies, Faith E. ^{[3
,4
]}

Bell, Sue E. ^{[2
]}

Cook, Gordon ^{[1
]}

Szubert, Alexander J. ^{[2
]}

Drayson, Mark T. ^{[5
]}

Jackson, Graham H. ^{[6
]}

Morgan, Gareth J. ^{[3
,4
]}

Owen, Roger G. ^{[1
]}

机构：

[1] St Jamess Inst Oncol, Leeds, W Yorkshire, England

[2] Univ Leeds, Clin Trials Res Unit, Leeds LS2 9JT, W Yorkshire, England

[3] Inst Canc Res, London, England

[4] Univ Arkansas Med Sci, Little Rock, AR 72205 USA

[5] Univ Birmingham, Birmingham B15 2TT, W Midlands, England

[6] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

来源：

HAEMATOLOGICA | 2016年 / 101卷 / 02期

基金：

英国医学研究理事会;

关键词：

minimal residual disease; myeloma; induction; flow cytometry; MULTIPARAMETER FLOW-CYTOMETRY; MULTIPLE-MYELOMA; SURVIVAL; TRIAL; IX; THALIDOMIDE;

D O I：

10.3324/haematol.2015.128215

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E69 / E71

页数：3

共 9 条

[1] Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial [J].

Boettcher, Sebastian ;

Ritgen, Matthias ;

Fischer, Kirsten ;

Stilgenbauer, Stephan ;

Busch, Raymonde M. ;

Fingerle-Rowson, Guenter ;

Fink, Anna Maria ;

Buehler, Andreas ;

Zenz, Thorsten ;

Wenger, Michael Karl ;

Mendila, Myriam ;

Wendtner, Clemens-Martin ;

Eichhorst, Barbara F. ;

Doehner, Hartmut ;

Hallek, Michael J. ;

Kneba, Michael .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (09) :980-988

[2] Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium [J].

Landgren, Ola ;

Gormley, Nicole ;

Turley, Danielle ;

Owen, Roger G. ;

Rawstron, Andy ;

Paiva, Bruno ;

Barnett, David ;

Arroz, Maria ;

Wallace, Paul ;

Durie, Brian ;

Yuan, Constance ;

Dogan, Ahmet ;

Stetler-Stevenson, Maryalice ;

Marti, Gerald E. .

AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (12) :1159-1160

[3] Minimal residual disease in multiple myeloma: bringing the bench to the bedside [J].

Mailankody, Sham ;

Korde, Neha ;

Lesokhin, Alexander M. ;

Lendvai, Nikoletta ;

Hassoun, Hani ;

Stetler-Stevenson, Maryalice ;

Landgren, Ola .

NATURE REVIEWS CLINICAL ONCOLOGY, 2015, 12 (05) :286-U139

[4] Long-term Follow-up of MRC Myeloma IX Trial: Survival Outcomes with Bisphosphonate and Thalidomide Treatment [J].

Morgan, Gareth J. ;

Davies, Faith E. ;

Gregory, Walter M. ;

Bell, Susan E. ;

Szubert, Alexander J. ;

Cook, Gordon ;

Drayson, Mark T. ;

Owen, Roger G. ;

Ross, Fiona M. ;

Jackson, Graham H. ;

Child, J. Anthony .

CLINICAL CANCER RESEARCH, 2013, 19 (21) :6030-6038

[5] Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results [J].

Morgan, Gareth J. ;

Davies, Faith E. ;

Gregory, Walter M. ;

Bell, Sue E. ;

Szubert, Alexander J. ;

Coy, Nuria Navarro ;

Cook, Gordon ;

Feyler, Sylvia ;

Johnson, Peter R. E. ;

Rudin, Claudius ;

Drayson, Mark T. ;

Owen, Roger G. ;

Ross, Fiona M. ;

Russell, Nigel H. ;

Jackson, Graham H. ;

Child, J. Anthony .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03) :442-450

[6] Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation [J].

Paiva, Bruno ;

Vidriales, Maria-Belen ;

Cervero, Jorge ;

Mateo, Gema ;

Perez, Jose J. ;

Montalban, Maria A. ;

Sureda, Anna ;

Montejano, Laura ;

Gutierrez, Norma C. ;

de Coca, Alfonso Garcia ;

Heras, Natalia de las ;

Mateos, Maria V. ;

Lopez-Berges, Maria C. ;

Garcia-Boyero, Raimundo ;

Galende, Josefina ;

Hernandez, Jose ;

Palomera, Luis ;

Carrera, Dolores ;

Martinez, Rafael ;

de la Rubia, Javier ;

Martin, Alejandro ;

Blade, Joan ;

Lahuerta, Juan J. ;

Orfao, Alberto ;

Miguel, Jesus F. San .

BLOOD, 2008, 112 (10) :4017-4023

[7] High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma [J].

Paiva, Bruno ;

Gutierrez, Norma C. ;

Rosinol, Laura ;

Vidriales, Maria-Belen ;

Montalban, Maria-Angeles ;

Martinez-Lopez, Joaquin ;

Mateos, Maria-Victoria ;

Cibeira, Maria-Teresa ;

Cordon, Lourdes ;

Oriol, Albert ;

Terol, Maria-Jose ;

Echeveste, Maria-Asuncion ;

de Paz, Raquel ;

de Arriba, Felipe ;

Palomera, Luis ;

de la Rubia, Javier ;

Diaz-Mediavilla, Joaquin ;

Sureda, Anna ;

Gorosquieta, Ana ;

Alegre, Adrian ;

Martin, Alejandro ;

Hernandez, Miguel T. ;

Lahuerta, Juan-Jose ;

Blade, Joan ;

San Migue, Jesus F. .

BLOOD, 2012, 119 (03) :687-691

[8] Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction [J].

Rawstron, Andy C. ;

Gregory, Walter M. ;

de Tute, Ruth M. ;

Davies, Faith E. ;

Bell, Sue E. ;

Drayson, Mark T. ;

Cook, Gordon ;

Jackson, Graham H. ;

Morgan, Gareth J. ;

Child, J. Anthony ;

Owen, Roger G. .

BLOOD, 2015, 125 (12) :1932-1935

[9] Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study [J].

Rawstron, Andy C. ;

Child, J. Anthony ;

de Tute, Ruth M. ;

Davies, Faith E. ;

Gregory, Walter M. ;

Bell, Sue E. ;

Szubert, Alexander J. ;

Navarro-Coy, Nuria ;

Drayson, Mark T. ;

Feyler, Sylvia ;

Ross, Fiona M. ;

Cook, Gordon ;

Jackson, Graham H. ;

Morgan, Gareth J. ;

Owen, Roger G. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) :2540-+

← 1 →